Lamoureux et al.18 demonstrated that PI3K–AKT pathway activation is associated with poor clinical outcomes of PCa patients; similarly, Kreisberg et al.19 showed that activation (phosphorylation) of AKT is a predictor of poor clinical outcome in PCa. The gene discussed is AKT1; the disease is posterior cortical atrophy.